SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?


To: VBroady who wrote (703)11/20/1998 1:41:00 AM
From: Tagore  Read Replies (1) | Respond to of 1255
 
It won't be over until the holders of the $2.5MM convertible preferred have completely converted into common and sold out their entire position. Maybe that has already happened. In any event we will see a $1.00+ per share shortly after that happens. When the company sold this position to private investors they permitted them to obtain conversion rights without specifying any floor - and this is the result. The preferred holders do not care how low the price goes as long as there is volume. Just read the 10K that came with the annual report. It's all in there. It's an artificial, but extremely painful situation and we are seeing serious dilution now. They waited until after Sept. 30 to begin converting and selling so as not to show their hand in the 10Q. When it stops raining shares the sun might start to shine again a little on those of us who are long time holders. Good luck to all of you.



To: VBroady who wrote (703)11/20/1998 6:30:00 AM
From: Cage Rattler  Respond to of 1255
 
VBroady:

CORX has a very long way to climb; hopefully the "dime" is not the famed "dead cat" bounce. There is a December 15, stock-holder meeting -- there should be a meaningful data exchange from CORX or else.

Ciao, Ted